SCHEMBL25665804

SCHEMBL25665804

Cc1cccc(C(c2ccccc2)N(C)C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 1/20 0.54
ACP3 P15309 1/20 0.47
AOC3 Q16853 1/20 0.44
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
ACHE P22303 2/20 0.42
TAAR1 Q96RJ0 1/20 0.42
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
NPSR1 Q6W5P4 1/20 0.39
EPHX1 P07099 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPT P10636 2/20 0.38
OPRM1 P35372 2/20 0.38
OPRD1 P41143 2/20 0.38
OPRK1 P41145 1/20 0.38
OPRL1 P41146 1/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674996 0.82 CHRNA7 (0.59) CHRNA7AOC3KDM4EALDH1A1SLC6A2
Hydrochloric Acid SCHEMBL11332719 0.80 CHRNA7 (0.56) CHRNA7AOC3KDM4EALDH1A1SLC6A2
Bromide SCHEMBL10595079 0.80 CHRNA7 (0.56) CHRNA7AOC3KDM4EALDH1A1SLC6A2
Water SCHEMBL28355612 0.80 CHRNA7 (0.56) CHRNA7AOC3KDM4EALDH1A1SLC6A2
SCHEMBL31013838 0.76 SLC6A2 (0.47) ACP3AOC3ALDH1A1ACHETAAR1
SCHEMBL23429115 0.75 ACP3 (0.44) ACP3AOC3ALDH1A1TAAR1SLC6A2
SCHEMBL11604400 0.75 ACP3 (0.55) ACP3AOC3KDM4EALDH1A1ACHE
SCHEMBL16363245 0.75 ACHE (0.49) ACP3AOC3ALDH1A1ACHEMAPT
SCHEMBL19724322 0.75 ACHE (0.49) ACP3AOC3ALDH1A1ACHEMAPT
SCHEMBL19122026 0.75 ACHE (0.49) ACP3AOC3ALDH1A1ACHEMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4180424-A1 SUBSTITUTED PYRAZOLES AS HUMAN PLASMA KALLIKREIN INHIBITORS BioCryst Pharmaceuticals, Inc. (US) 2023-05-17 EP disclosed